Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.270
0.00 (0.00%)
May 6, 2026, 3:28 PM EDT - Market open
Pulmonx Stock Forecast
Stock Price Forecast
The 7 analysts that cover Pulmonx stock have a consensus rating of "Buy" and an average price target of $5.38, which forecasts a 323.62% increase in the stock price over the next year. The lowest target is $2.50 and the highest is $14.
Price Target: $5.38 (+323.62%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pulmonx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,002.36% | Apr 30, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +293.70% | Mar 5, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,002.36% | Mar 5, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,002.36% | Feb 20, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +1,002.36% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
92.74M
from 90.50M
Increased by 2.48%
Revenue Next Year
109.86M
from 92.74M
Increased by 18.46%
EPS This Year
-1.16
from -1.33
EPS Next Year
-0.87
from -1.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 95.9M | 158.7M | ||||||
| Avg | 92.7M | 109.9M | ||||||
| Low | 88.2M | 92.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 6.0% | 71.2% | ||||||
| Avg | 2.5% | 18.5% | ||||||
| Low | -2.5% | -0.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.17 | -0.09 | ||||||
| Avg | -1.16 | -0.87 | ||||||
| Low | -1.15 | -1.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.